骨髓纤维化时骨髓增殖性肿瘤患者血小板具有独特转录本特征
研究探讨骨髓增殖性肿瘤(MPN)伴骨髓纤维化患者的血小板转录组变化。通过对训练队列和独立测试队列的血小板进行二代测序,发现骨髓纤维化存在时血小板转录本有离散改变,并鉴定出3基因纤维化特征(CCND1、H2AX、CEP55),该特征在测试队列中区分有无骨髓纤维化的阳性预测值为71%(特异性93%,敏感性71%)。
要点
- MPN伴骨髓纤维化患者血小板转录组存在离散改变。
- 3基因特征(CCND1、H2AX、CEP55)可区分有无骨髓纤维化,阳性预测值71%。
- 血小板转录本监测可能有助于早期预测MPN向骨髓纤维化进展。
核心结论
- MPN患者血小板在骨髓纤维化存在时具有独特转录本特征,3基因特征可区分有无骨髓纤维化。
研究设计与样本
- 研究纳入伴或不伴纤维化的MPN患者及非恶性对照个体,采用二代测序评估血小板转录本,并设训练队列和独立测试队列。
主要发现
- 训练队列中发现骨髓纤维化存在时血小板转录本有离散改变,鉴定出超过1000个差异表达转录本。
- 从差异转录本中识别出3基因纤维化血小板特征:CCND1、H2AX(原H2AFX)和CEP55。
- 在独立测试MPN患者队列中盲法评估,3基因特征区分有无骨髓纤维化的阳性预测值为71%(特异性93%,敏感性71%)。
关键数值与推荐
- 3基因纤维化血小板特征(CCND1、H2AX、CEP55)区分骨髓纤维化的阳性预测值71%,特异性93%,敏感性71%。
临床怎么用
- 评估血小板中失调转录本可能作为MPN监测工具,用于识别向骨髓纤维化进展。
- 序贯监测可能有助于早期预测向纤维化进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Marrow fibrosis is a significant complication of myeloproliferative neoplasms (MPN) that affects up to 20% of patients and is associated with a poor prognosis. The pathological processes that lead to fibrotic progression are not well understood, but megakaryocytes have been implicated in the process. The aim of this study was to determine whether platelets, derived from megakaryocytes, have transcriptomic alterations associated with fibrosis. Platelets from MPN patients with and without fibrosis and non-malignant control individuals were assessed using next generation sequencing. Results from the initial training cohort showed discrete changes in platelet transcripts in the presence of marrow fibrosis. We identified more than 1000 differentially expressed transcripts from which a putative 3-gene fibrotic platelet signature (CCND1, H2AX [previously termed H2AFX] and CEP55) could be identified. This fibrosis-associated signature was assessed blinded on platelets from an independent test MPN patient cohort. The 3-gene signature was able to discriminate between patients with and without marrow fibrosis with a positive predictive value of 71% (93% specificity, 71% sensitivity). This demonstrates that assessment of dysregulated transcripts in platelets may be a useful monitoring tool in MPN to identify progression to marrow fibrosis. Further, sequential monitoring could have clinical applications for early prediction of progression to fibrosis.
引用
- Guo BB, Linden MD, Fuller KA, et al. Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis. Br J Haematol. 2019. PMID: 31426129. doi:10.1111/bjh.16152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。